NCT07276542: Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 30 planned
- Started
- 15 Jan 2026
- Primary completion
- 31 Dec 2026
- Arms
- PLP Ketamine Intervention
- Results
- None posted
- 11 Dec 2025: Trial registered
- 15 Jan 2026: Trial started